✦ LIBER ✦

The use of primary myotubes and fibroblasts for the evaluation of pharmacological chaperone therapy in Pompe disease

✍ Scribed by Westbroek, Wendy; Tamargo, Rafael J.; Xiao, Jingbo; Soska, Rebecca; Valenzano, Kenneth J.; Goldin, Ehud; Khanna, Richie; Marugan, Juan J.; Sidransky, Ellen

Book ID: 122080931
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 63 KB
Volume: 108
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2012.11.268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exploring the use of a co-formulated pha

Exploring the use of a co-formulated pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase for Pompe disease

✍ Khanna, Richie; Xu, Su; Lun, Yi; Soska, Rebecca; Feng, Jessie; Frascella, Michel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

M.P.5.09 Pharmacological chaperone thera

M.P.5.09 Pharmacological chaperone therapy for the treatment of Pompe disease: Deoxynojirimycin increases lysosomal levels and specific activity of acid alpha-glucosidase

✍ B. Wustman; A. Powe Jr.; J. Flanagan; R. Khanna; W. Liang; X. Wu; R. Dhulipala; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Use of the muscle volume analyzer to eva

Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease

✍ Fuminobu Sugai; Yosuke Kokunai; Yoichi Yamamoto; Goichi Hashida; Kengo Shimazu; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 260 KB

Exploring the Use of Pharmacological Cha

Exploring the Use of Pharmacological Chaperone AT3375 Alone and in Combination with Recombinant human ß-Glucosidase for Gaucher Disease

✍ Richie Khanna; Lee Pellegrino; Rebecca Soska; Yi Lun; Jessie Feng; Michelle Fras 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

G.P.8.05 The pharmacological chaperone A

G.P.8.05 The pharmacological chaperone AT2220 increases mutant acid alpha-glucosidase levels and reduces tissue glycogen in a mouse model of Pompe disease

✍ R. Khanna; R. Soksa; J. Feng; Y. Lun; A.C. Powe; J. Flanagan; H. Do; D.J. Lockha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB

G.P.11.05 The pharmacological chaperone

G.P.11.05 The pharmacological chaperone AT2220 increases trafficking, processing, and cellular activity of acid α-glucosidase and is a potential new treatment for Pompe disease

✍ A.C. Powe; J.F. Flanagan; R. Khanna; X. Wu; W. Liang; R. Dhulipala; T. Yin; K. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB